The relatively high proportion of FHL-1, as compared to factor H, in the SK-OV-3 and Caov-3 cell growth supernatants (Figure 3B) suggested that FHL-1 may have a role in the control of the alternative C pathway activation against tumour cells. The gene discussed is FHL1; the disease is neoplasm.